MsNatasha Stevens
(she/her)
Senior Program Manager - Multiple Sclerosis Research Flagship
Menzies Institute for Medical Research
- Senior Program Manager - Multiple Sclerosis Research FlagshipMenzies Institute for Medical Research
RESEARCH SUMMARy
Natasha has directly managed the design, conduct and completion of 12 multicentre, randomised, controlled trials (RCTs) and provided quality assurance and operational oversight for more than 50 RCTs. Her experience focusses on investigator led trials in Australia and the UK, from phase I to phase III, drug, device, advanced therapy, and complex interventional trials, with experience implementing parallel, cross over, cluster randomised, and step wedged designs. This experience extends to various therapeutic areas, including human immunodeficiency virus (HIV), Epstein Barr virus (EBV), cancer (nasopharyngeal carcinoma (NPC) and glioblastoma), respiratory diseases, women’s health, functional bowel disorders and multiple sclerosis (MS). This extensive and varied experience in implementing clinical trials, provides a unique understanding of national and international clinical trial regulations and guidelines, including European Union (EU) and United States (FDA), Australian (TGA), and UK (MHRA) regulatory environments, with practical application of ethics and governance requirements, clinical trial feasibility and protocol implementation, database design, data management, quality control, quality assurance and monitoring to audit standards, along with advanced finance, governance, reporting, and stakeholder management experience, with a particularly keen interest in consumer and community involvement in research, clinical trial methodology, research translation and impact.
FUNDED PROJECTS
- CONSULTANCY/CONTRACT RESEARCHPLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis (PLATYPUS)8 Jul 2026 - 15 Mar 2030People funded by this grant:
- Taylor B,
- Foong YC,
- Stevens N,
- Ng YZJ,
- Young K
- GRANTCentre of multiple sclerosis research translation1 Jul 2024 - 30 Jun 2029People funded by this grant:
- Young K,
- Taylor B,
- Reay W,
- van der Mei I,
- Zhou Y
- GRANTWHAT CAUSES MULTIPLE SCLEROSIS ONSET AND PROGRESSION?1 Jan 2024 - 31 Dec 2028People funded by this grant:
- Young K,
- Fletcher J,
- Blackburn N
- GRANTUnravelling the interplay between EBV genomics and host T cell immune regulation in multiple sclerosis1 Jun 2023 - 31 May 2027People funded by this grant:
- Zhou Y,
- Smith C,
- Taylor B,
- Khanna R,
- Liu J
- CONSULTANCY/CONTRACT RESEARCHPregnancy and Multiple Sclerosis Outcomes1 Jan 2023 - 31 Dec 2024People funded by this grant:
- Taylor B
- CONSULTANCY/CONTRACT RESEARCHUnderstanding MS MOOC extension1 Jan 2023 - 31 Dec 2028People funded by this grant:
- Taylor B
- CONSULTANCY/CONTRACT RESEARCHMerck Evolution - MS0200527-00801 Jan 2020 - 31 Dec 2025People funded by this grant:
- Taylor B,
- Hussain A
- GRANTThe Menzies Multiple Sclerosis Flagship Program1 Jan 2020 - 30 Jun 2024People funded by this grant:
- Taylor B,
- Young K,
- Charlesworth J,
- van der Mei I,
- Palmer A
- CONSULTANCY/CONTRACT RESEARCHUnderstanding MS MOOC (Massive Open Online Course)1 Jan 2018 - 31 Dec 2022People funded by this grant:
- Taylor B,
- Claflin S,
- van der Mei I